Skip to main content
Fig. 5 | Pediatric Rheumatology

Fig. 5

From: Reduction in the utilization of prednisone or methotrexate in Canadian claims data following initiation of etanercept in pediatric patients with juvenile idiopathic arthritis

Fig. 5

Mean Dose of (a) Methotrexate or (b) Prednisone Pre- and Post-initiation of Etanercept*. JIA, juvenile idiopathic arthritis; MTX, methotrexate; PRD, prednisone. Indications were inferred using an algorithm developed by IQVIA, which utilizes a patient’s drug history [7, 8, 30]. *These results are from the patients who continued taking these co-medications after the initiation of etanercept. All indications refers to patients with a drug history representing juvenile idiopathic arthritis, psoriatic arthritis, or ankylosing spondylitis

Back to article page

Pediatric Rheumatology

ISSN: 1546-0096